文献速递瓣膜外科

新型双叶瓣覆膜支架经导管三尖瓣置换的首次实验数据

Catheter-based tricuspid valve replacement: first experimental data of a newly designed bileaflet stent graft prosthesis.
PubMed 文献 · Eur J Cardiothorac Surg · 2017-01-01

本研究报道一种新型猪心包覆盖镍钛合金双叶瓣支架经导管三尖瓣置换的首次动物实验。在7只绵羊模型中经股静脉成功植入装置,6只位置正确且双腔静脉密封良好,全部动物瓣膜功能正常且存活至择期处死。结论认为该装置可安全递送并正确定位,但需在创建三尖瓣反流后的长期动物实验中验证血流动力学获益。

要点

  • 新型双叶瓣覆膜支架经股静脉途径可安全植入绵羊模型。
  • 7只动物中6只装置位置正确且双腔静脉密封良好。
  • 全部动物瓣膜功能正常、无持续心律失常并存活至择期处死。

核心结论

  • 该新型带瓣覆膜支架在绵羊模型中可安全递送,定位正确且瓣膜功能正常。
  • 需在创建三尖瓣反流后的长期动物实验中进一步验证该术式的血流动力学获益。

研究设计与样本

  • 研究为新型经导管三尖瓣置换装置的首次动物实验。
  • 装置为猪心包覆盖的镍钛合金覆膜支架,带侧向双叶瓣,先在尸体研究中适配尺寸。
  • 体外灌注装置完成血流动力学测试后,在绵羊动物模型(n=7)中评估血管入路、瓣膜递送与功能。

主要发现

  • 装置在全部动物中成功植入。
  • 经股静脉外科建立血管入路,无血管并发症。
  • 血管造影显示6只动物装置位置正确且双腔静脉密封良好。
  • 1只体型极大动物的装置位置偏头侧但仍可接受。
  • 全部动物经血管造影和超声心动图证实瓣膜功能正常,除瓣膜植入期间外无持续心律失常。

临床怎么用

  • 该装置为三尖瓣反流的经导管治疗提供了新的实验性选择。
  • 目前仅为动物实验数据,尚不能直接用于临床决策。

局限性

  • 研究为动物实验,样本量小(n=7)。
  • 未在创建三尖瓣反流模型后评估装置的血流动力学获益。
  • 缺乏长期随访数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Moderate or severe degree tricuspid valve regurgitation (TVR) is associated with high rates of morbidity and mortality. Surgical correction as the only therapeutic option offers unsatisfactory results. Recently, several interventional procedures have been introduced clinically in a limited cohort. We present our initial experiments with an innovative interventional valved stent graft for treatment of TVR. METHODS: A newly designed porcine pericardium-covered nitinol stent graft with a lateral bicuspid valve was adapted to size in a cadaver study. After haemodynamic testing in an ex vivo perfusion setup, vascular access, valve delivery and function were investigated in an ovine animal model ( n = 7). RESULTS: The device was implanted successfully in all animals. Vascular access was established surgically via the femoral vein without any vascular complications. Angiography demonstrated the correct position of the device with proper sealing of both venae cavae in 6 animals. In 1 extremely large animal, the position of the device was considered too cranial but still acceptable. Correct valve function was verified in all animals by both angiography and echocardiography. There were no persistent arrhythmias other than during valve implant. All animals survived the implant procedure and were sacrificed electively. CONCLUSIONS: This study demonstrated that this new valved stent graft could be delivered safely with correct positioning and valve function in this ovine model. Further long-term studies in animals implanted with the device after creation of tricuspid regurgitation are necessary to prove the haemodynamic benefit of this procedure.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Lausberg HF, Gryszkiewicz R, Kuetting M, et al. Catheter-based tricuspid valve replacement: first experimental data of a newly designed bileaflet stent graft prosthesis. Eur J Cardiothorac Surg. 2017. PMID: 28430904. doi:10.1093/ejcts/ezx084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。